Newer clot-buster may offer a safe, effective way to treat ischemic stroke in mobile stroke units

Compared with the standard clot-busting medication alteplase, the newer clot-buster tenecteplase may offer a safe, effective and simpler way to treat ischemic (clot-caused) stroke in mobile stroke units, according to real-world experiences detailed in a preliminary study to be presented at the American Stroke Association’s International Stroke Conference 2024.

Significant Left Nasal Obstruction Finally Diagnosed After 2 Years

What caused a 65-year-old man with poorly controlled hypertension to develop an obstruction in his left nasal cavity 2 years ago? That’s what Chia-Hsiang Fu,

December 27, 2023

After AdCom rejection, FDA rebuffs Novo Nordisk’s once-weekly insulin

In May, the FDA Endocrinologic and Metabolic Drugs Advisory Committee (AdCom) voted 7-4 against the approval of Novo Nordisk’s icodec once-weekly insulin icodec for treating

July 11, 2024

Paying Docs for Prior Authorizations Among the Hot Topics at the AMA Meeting

Paying physicians and their staff for their time spent on dealing with prior authorization requests and denials was a lively topic of conversation at Saturday’s

November 11, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.